Selecta Biosciences Merges With Cartesian Therapeutics In All-stock Deal
Selecta Biosciences, Inc. (SELB) announced Monday that it has merged with biotechnology company Cartesian Therapeutics, Inc. In connection with the merger, Selecta announced a $60.
Source: rttnews.com